RonIsWrong Posted - 2 hours ago

$ANNX well shit, I'm going to get out of the market's way right now. Bios likely to get a spanking Will pick it up again after

ducslayer Posted - 19 hours ago

$ANNX There you have it . Filed 4/22 very nice . Another reason for the drop aside from options expiration .

Tshanky_ Posted - 23 hours ago

$ANNX should at least test the 6 especially with the upcoming catalyst. Maybe back to high

buyhiselow Posted - 23 hours ago

$ANNX what’s with the implied volatility in the options market? Is there some big catalyst coming up before 5/17? I honestly only noticed the implied volatility and know nothing about this stock.

RonIsWrong Posted - 1 day ago

$ANNX ownership (BB BIOTECH AG in with 4.68M shares reported on 4/22)

RonIsWrong Posted - 1 day ago

$ANNX back to buy spot. let's see how it behaves now.

Tshanky_ Posted - 1 day ago

$ANNX this was on my yearly list for a q2 add. I’m in! @everydayCPA alerted me. He’s one of my favorite follows. Phase 3 data coming this Q! (Still have the other bio I mentioned earlier coming soon)

AlertsAndNews Posted - 1 day ago

Updated Gappers in after hours trading $CSSE $RXRX $APDN $TSLA $ANNX Great day, let's do it again tomorrow.

SkSk_ Posted - 1 day ago

$ANNX what’s up with this AH volume ? ~15K shares isn’t a ton traded but more than usual for this stock after hours. weird. Figured I’d find a press release that gave a more clear timeline for data but I see no news.

GoCoogs Posted - 1 day ago

$ANNX Not huge volume but what's up with the after hours trading today? I am not seeing any news to drive up the price.

GoCoogs Posted - 2 days ago

$ANNX Stuck in the mud

chrisjam92 Posted - 5 days ago

$ANNX

chrisjam92 Posted - 5 days ago

$ANNX don't forget options expiry today. I think next week we start our uptrend again.

GoCoogs Posted - 1 week ago

$ANNX Looks like we hopefully may finally have our reversal. Chart showed that we needed to bounce off the 4.40 area which was the recent low on 3/11 & 3/12.

LabPsycho Posted - 1 week ago

$ANNX A Study to Evaluate the Efficacy and Safety of Eculizumab in Guillain-Barré Syndrome https://classic.clinicaltrials.gov/ct2/show/NCT04752566

GSP Posted - 1 week ago

I don't love this setup, but $ANNX makes the list for Thursday.

GSP Posted - 1 week ago

The final four stocks in my video for April 18th: $AAPL $HYMC $TRNO $ANNX Watch here: https://greatstockpix.com/april-18th-day-trading-watch-list/

LabPsycho Posted - 1 week ago

$ANNX @Bioinvest2020 This is what an outstanding post and contribution looks like (see below)

LabPsycho Posted - 1 week ago

$ANNX $400M shelf before pivotal data is not a good look. That and most biotechs are cratering.

GoCoogs Posted - 1 week ago

$ANNX Relentless selling

Bioinvest2020 Posted - 1 week ago

@SkSk_ C5 inhibitor eculizumab (Soliris) failed its Ph3 GBS trial. Not placebo controlled and study was not stratified, but one could interpret this as suggesting that complement inhibition is not materially efficacious over standard off-label IVIg therapy. There's also the risk re patient comparability. There was no way for $ANNX to conduct a placebo controlled GBS trial in US or EU given availability and use of IVIg as first-line therapy, and conducting an ex-US study as they've done here allows them to do so. But even success in $ANNX Ph3 GBS trial will thus necessarily be dependent on positive data from data / patient comparability study in 1H 2025. I am bullish on the stock, and have been for several years. The GBS study design here is much more robust than that of eculizumab (significantly higher power, stratified, better inclusion criteria, GBS-DS endpoint) and EMA has previously commented on robustness of Ph1b comparability data submitted in support of orphan drug designation.

SkSk_ Posted - 1 week ago

$ANNX does anyone have a scientific bear case on why the GBS trial might fail? Anyone familiar with C1q inhibition MoA? I am bullish here mainly because of all the specialty bio funds loading this stock in Q4 2023. also lots of whales are loading July $7.5C but I would be interested in hearing a potential bear case about the science/trial itself. cannot invest safely without first being contrarian. TIA.

BriamG316 Posted - 1 week ago

$ANNX This will explode like it just did today $SINT

LabPsycho Posted - 1 week ago

$ANNX Perhaps "JP Morgan’s "5-star biotech expert Anupam Rama" would have the integrity to either admit he was wrong or admit his buy recommendation was merely part of a pump and dump prior the the $400M offering? Or maybe other folks at JP Morgan read my original thinking pros and con ideas on ANNX, unlike Rama trite remarks that went along with his buy recommendation?

GoCoogs Posted - 1 week ago

$ANNX 44% (so far) drop from its recent high of $8.40. Unreal.

mikeparaiso Posted - 1 week ago

$ANNX Buying at $4.10 !!

Crop1987 Posted - 1 week ago

$ANNX at -0.63 a day this mf will ne at 0.00 before next

Stock_Titan Posted - 1 week ago

$ANNX Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/ANNX/annexon-reports-inducement-grants-to-new-employees-under-nasdaq-w515zvfx4qbc.html

GrumpySasquatch Posted - 1 week ago

$ANNX

GoCoogs Posted - 1 week ago

$ANNX MFer crashing now